Overview

Vascular Inflammation and Cholesterol Lowering Therapy

Status:
Withdrawn
Trial end date:
2020-10-01
Target enrollment:
Participant gender:
Summary
This study aim to detect change in vascular inflammation following intense lipid lowering therapy
Phase:
Phase 4
Details
Lead Sponsor:
Rigshospitalet, Denmark
Treatments:
Evolocumab